Newswise — Grand Rapids, Mich – October 3, 2012 – Among the latest discoveries in preventive care is a FDA-cleared antiemetic (non-drug) disposable acupressure wrist strip under the brand name Pressure Right®. This product empowers surgery patients to respond more favorably against PONV occurrences and because of improved patient satisfaction there is less demands placed on PACU nurses to treat PONV episodes.
With Medicare cuts of $10.7 billion looming in 2013, PONV management care may prove burdensome and more difficult for clinical practitioners as a result of disconcerting potential job losses at hospitals. The slow-to-change US healthcare system will now need to undertake a much broader view of beneficial outcomes heavily focusing on preventive measure efficiencies that promote Medicare savings compared to follow-on costly treatment protocols.
The Pressure Right® wrist strip provides adhesion to the P6 acupressure point on the skin’s surface to perform a clinically proven preventive outcome against the effects of PONV, which are commonplace after surgery. This adhesion process to the skin surface focuses on activating the P6 stimulation mechanism in the body to block the human condition that can bring on the advent of postoperative side effects such as nausea and vomiting.
With the use of the company’s unique P6 locator strip, the effective implementation of the wrist strip can be applied on both wrists in 60 seconds or less by the nursing staff. The wrist strip is intended to be used as an enhanced antiemetic adjunct prior to the induction of anesthesia and can remain on the patient’s wrists for up to 72 hours with no known side effects. Under clinical trial conditions, Pressure Right® has proven to provide a 72 hour window of PONV prophylactic effectiveness following surgery.
In a recent Tripp Umbach study released last month commissioned by the American Hospital Association (AHA) entitled: The Negative Employment Impacts of the Medicare Cuts in the Budget Control Act of 2011, it measured the impact of the 2% mandated cuts in Medicare spending over the next nine years from 2013 until 2021 triggered by the failure of Congress to create a deficit-reduction plan. As a result, the study concluded that a work force reduction at hospitals will approach nearly 93,000 fewer jobs next year. Tripp Umbach is the leading provider of economic impact analysis for hospitals and health systems and serves more than 50 of the nation’s leading 100 healthcare organizations.
The unintended consequences could mean fewer medical assistants, nursing staff and other health practitioners, which will create an understaffed environment at hospitals across the country. The utilization of future hospital services will become a paramount issue as well as a major concern for practitioners starting early next year.
Additionally the Tripp Umbach study indicates that among the States that will be hardest hit are California, Florida, Texas, New York and Pennsylvania, which are expected to be negatively impacted by nearly 175,000 fewer jobs in 2013, or about 35% of the total estimated direct and indirect job losses projected at 496,429 next year.
Another interesting employment impact number in the report is that by 2021 the annual automatic 2% Medicare funding cuts, which are projected to reach a total of $118.8 billion, will have a projected negative employment impact of almost 767,000 fewer jobs in the US economy by 2021.
The PONV phenomenon is still a long-standing problem for anesthesia practitioners, despite the routine combination use of prophylactic antiemetic drugs. Coupled with the pending staff reductions next year, treating PONV will only put extra stress on the healthcare system at large. The necessity for broader PONV reforms to include other competent preventive measures will need to come to the forefront and be adopted in order to fill the employment void that will be created by the Medicare spending cuts starting in 2013.
Pressure Right® is a cost-efficient, proprietary prescription-based product developed for adjunct use to enhance the efficacy and safety in PONV preventive care.
Additional information on the cost-effective performance benefits of Pressure Right® as well as the link to the Tripp Umbach economic impact analysis report can be obtained by directly contacting the company.
Email: [email protected]
Website: www.pressurepointstrip.com
RSS